UniProt Q8L0V4
Q8L0V4
Q8L0V4 (UniProt Q8L0V4): 4 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- Q8L0V4
- Experimental structures
- 4
- Predicted models
- 1
Structures
5 records of Q8L0V4 in the MolNFT archive: 4 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2Z86 | Crystal structure of chondroitin polymerase from Escherichia coli strain K4 (K4CP) complexed with… | x-ray diffraction | A, B, C, D | — | — |
| 2Z86 | Crystal structure of chondroitin polymerase from escherichia COLI strain K4 (K4CP) complexed with… | x-ray diffraction | A, B, C, D | — | — |
| 2Z87 | Crystal structure of chondroitin polymerase from Escherichia coli strain K4 (K4CP) complexed with… | x-ray diffraction | A, B | — | — |
| 2Z87 | Crystal structure of chondroitin polymerase from escherichia COLI strain K4 (K4CP) complexed with… | x-ray diffraction | A, B | — | — |
| Q8L0V4 | AlphaFold monomer V2.0 prediction for chondroitin synthase (Q8L0V4) | predicted | A | — | — |
Experiment against prediction
- 2Z86 chain A against the predicted model Q8L0V4: TM-score 0.99, RMSD 1.00 Å
- 2Z86 chain A against the predicted model Q8L0V4: TM-score 0.99, RMSD 1.00 Å
- 2Z87 chain B against the predicted model Q8L0V4: TM-score 0.99, RMSD 1.28 Å
- 2Z87 chain B against the predicted model Q8L0V4: TM-score 0.99, RMSD 1.28 Å
- 2Z86 chain B against the predicted model Q8L0V4: TM-score 0.98, RMSD 1.39 Å
- 2Z86 chain B against the predicted model Q8L0V4: TM-score 0.98, RMSD 1.39 Å
- 2Z86 chain D against the predicted model Q8L0V4: TM-score 0.98, RMSD 1.17 Å
- 2Z86 chain D against the predicted model Q8L0V4: TM-score 0.98, RMSD 1.17 Å
- 2Z86 chain C against the predicted model Q8L0V4: TM-score 0.98, RMSD 1.43 Å
- 2Z86 chain C against the predicted model Q8L0V4: TM-score 0.98, RMSD 1.43 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.